Adapted strategy to tumor response in childhood nasopharyngeal carcinoma: the French experience

医学 鼻咽癌 放射治疗 化疗 诱导化疗 咽痛 阶段(地层学) 回顾性队列研究 内科学 放化疗 外科 肿瘤科 古生物学 生物 食管
作者
A. Jouin,Sylvie Helfré,Stéphanie Bolle,L. Claude,A. Laprie,Émilie Bogart,C. Vigneron,H. Potet,A. Ducassou,Audrey Claren,F.-G. Riet,Marie Pierre Castex,Cécile Faure‐Conter,Brice Fresneau,Anne‐Sophie Defachelles,Daniel Orbach
出处
期刊:Strahlentherapie Und Onkologie [Springer Science+Business Media]
卷期号:195 (6): 504-516 被引量:21
标识
DOI:10.1007/s00066-019-01461-6
摘要

The aim of this study was to retrospectively study survival and long-term morbidities of children with nasopharyngeal carcinoma (NPC) treated by induction chemotherapy and concurrent chemoradiation (CRT). The total dose of radiation was adapted to the response following neoadjuvant chemotherapy. Children with non-metastatic NPC treated in France between 1999 and 2015 were retrospectively included in the study. The strategy combined neoadjuvant platinum-based chemotherapy, followed by adapted CRT to tumor response. In total, 95 patients (median age 15 years [range, 7–23 years], male-to-female ratio 1.8) with undifferentiated NPC were included; 59% of patients had TNM stage IV. Intensity-modulated radiotherapy (IMRT) was delivered to 57 patients (60%), while the other patients were treated with conformal RT (3D-RT). After a median follow-up of 4.5 years [range, 3.6–5.5 years], 13 relapses and seven deaths had occurred. The 3‑year overall and relapse-free survival (RFS) were 94% [95% CI, 85–97%] and 86% [77–92%], respectively. The locoregional failure rate was 6% [95% CI, 2–14]. Long-term treatment-related sequelae of grade 2+ were reported by 37 (50%) patients; odynophagia was significantly reduced treated by IMRT vs. conventional 3D-RT (7% vs. 55%, p = 0.015). Using a reduction dose of 59.4 Gy, 54 Gy, and 45 Gy, respectively, to the primary, involved, and uninvolved neck nodes, after a favorable tumor response, was not associated with an increased locoregional failure rate. The survival rates for NPC have been considerably improved by means of multimodal therapy, but long-term locoregional morbidity remains common. Use of IMRT may induce less residual odynophagia. Radiation dose reduction adapted to chemotherapy response does not have a negative impact on outcome. These findings support the use of an RT protocol adapted to the tumor response to neoadjuvant chemotherapy for a long-lasting improvement in the patient’s quality of life.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ffddsdc发布了新的文献求助10
1秒前
所所应助调皮摇伽采纳,获得10
2秒前
深情安青应助朴实寻琴采纳,获得10
3秒前
Ronin发布了新的文献求助10
3秒前
李爱国应助xiaolin采纳,获得10
4秒前
Naranja完成签到 ,获得积分10
5秒前
传奇3应助ESSIR采纳,获得30
6秒前
6秒前
无极微光应助烂漫冰烟采纳,获得20
6秒前
6秒前
6秒前
Orange应助xx采纳,获得10
7秒前
7秒前
7秒前
8秒前
余123完成签到,获得积分20
9秒前
9秒前
zhou完成签到,获得积分10
9秒前
10秒前
Singularity应助Wxt采纳,获得10
10秒前
勤奋真发布了新的文献求助10
11秒前
云纳发布了新的文献求助10
11秒前
11秒前
余123发布了新的文献求助10
11秒前
苏幕遮完成签到,获得积分10
11秒前
Jerry发布了新的文献求助10
12秒前
要苦就苦别人完成签到,获得积分10
12秒前
scalar完成签到 ,获得积分10
12秒前
12秒前
wyh发布了新的文献求助10
13秒前
脑洞疼应助郗文佳采纳,获得10
13秒前
王子诺完成签到,获得积分10
13秒前
flora发布了新的文献求助10
14秒前
朴实寻琴发布了新的文献求助10
15秒前
和和和完成签到,获得积分10
16秒前
bfsd凡发布了新的文献求助10
16秒前
情怀应助王子诺采纳,获得10
17秒前
可爱的函函应助xx采纳,获得10
17秒前
我要发nature完成签到,获得积分10
17秒前
顺心人达完成签到 ,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
AnnualResearch andConsultation Report of Panorama survey and Investment strategy onChinaIndustry 1000
機能性マイクロ細孔・マイクロ流体デバイスを利用した放射性核種の 分離・溶解・凝集挙動に関する研究 1000
卤化钙钛矿人工突触的研究 1000
Engineering for calcareous sediments : proceedings of the International Conference on Calcareous Sediments, Perth 15-18 March 1988 / edited by R.J. Jewell, D.C. Andrews 1000
Continuing Syntax 1000
Harnessing Lymphocyte-Cytokine Networks to Disrupt Current Paradigms in Childhood Nephrotic Syndrome Management: A Systematic Evidence Synthesis 700
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6259248
求助须知:如何正确求助?哪些是违规求助? 8081368
关于积分的说明 16884777
捐赠科研通 5331055
什么是DOI,文献DOI怎么找? 2837912
邀请新用户注册赠送积分活动 1815294
关于科研通互助平台的介绍 1669221